Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam

Sponsor
Number 2 Children's Hospital, Ho Chi Minh City (Other)
Overall Status
Completed
CT.gov ID
NCT05697887
Collaborator
(none)
45
1
3
29
1.6

Study Details

Study Description

Brief Summary

According to the World Health Organization, more than 50 million people have epilepsy. Among them, nearly 80% of epileptic patients live in developing countries and 75% of them do not have access to treatment. The ketogenic diet (KD) has been shown as an effective alternative for patients with drug-resistant epilepsy. Although it has been studied by few studies in Asia, no such studies have been conducted in Vietnam. The purpose of this study was to verify the feasibility, tolerability, and efficacy of the KD in children with refractory epilepsies followed at a pediatric center in South Vietnam.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Ketogenic diet
N/A

Detailed Description

Children with drug-resistant epilepsy followed at Children's Hospital No.2, Viet Nam treated by KD were included in a prospective study from June 2019 to October 2021. Side-effects, retention rate, number, and duration of seizures were recorded after 1, 3, 6, 9, and 12 months of KD. Patients were considered as responders when a 50% seizure frequency was reached. Tolerance and acceptability of the KD were closely monitored.

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Children with drug-resistant epilepsy followed at Children's Hospital No.2, Viet Nam treated by KD were included in a prospective study from June 2019 to October 2021. Side-effects, retention rate, number, and duration of seizures were recorded after 1, 3, 6, 9 and 12 months of KD. Patients were considered as responder when a 50% seizure frequency was reached. Tolerance and acceptability of the KD were closely monitored.Children with drug-resistant epilepsy followed at Children's Hospital No.2, Viet Nam treated by KD were included in a prospective study from June 2019 to October 2021. Side-effects, retention rate, number, and duration of seizures were recorded after 1, 3, 6, 9 and 12 months of KD. Patients were considered as responder when a 50% seizure frequency was reached. Tolerance and acceptability of the KD were closely monitored.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam
Actual Study Start Date :
Jun 1, 2019
Actual Primary Completion Date :
Oct 31, 2021
Actual Study Completion Date :
Oct 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: The feasibility of the ketogenic diet

The purpose of this study was to verify the feasibility of the ketogenic diet in children with refractory epilepsies followed at a pediatric center in South Vietnam. The patient was considered feasible if he (or she) did not have the contra-indication for the ketogenic diet

Dietary Supplement: Ketogenic diet
The ketogenic diet (KD) has been shown as an effective alternative for patients with drug-resistant epilepsy

Experimental: the tolerability of the ketogenic diet

The purpose of this study was to verify the tolerability of the ketogenic diet in children with refractory epilepsies followed at a pediatric center in South Vietnam. The patient was considered tolerant if he (or she) did not have any side effects caused by the ketogenic diet

Dietary Supplement: Ketogenic diet
The ketogenic diet (KD) has been shown as an effective alternative for patients with drug-resistant epilepsy

Experimental: the efficacy of the ketogenic diet

The purpose of this study was to verify the efficacy of the ketogenic diet in children with refractory epilepsies followed at a pediatric center in South Vietnam. Patients were considered responders when a 50% seizure frequency was reached.

Dietary Supplement: Ketogenic diet
The ketogenic diet (KD) has been shown as an effective alternative for patients with drug-resistant epilepsy

Outcome Measures

Primary Outcome Measures

  1. The feasibility of the ketogenic diet [12 months]

    Number of drug-resistant epilepsy patients without ketogenic diet's contra-indication

  2. The tolerability of the ketogenic diet at 12 months [12 months]

    Number of participants without ketogenic diet's side effect at 12 months

  3. The efficacy of the ketogenic diet at 12 months [12 months]

    The number of participants had a 50% seizure decrease at 12 months

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age from 1 to 10 years at the time of enrolment,

  • drug-resistant epilepsy according to the 2010 ILAE criteria,

  • an indication for a ketogenic diet trial according to the 2018 ILAE recommendations

Exclusion Criteria:
  • clinical or laboratory features suggesting an underlying disease contra-indication the use of a ketogenic diet

Contacts and Locations

Locations

Site City State Country Postal Code
1 N02 Children's Hospital Ho Chi Minh city Ho Chi Minh Vietnam 848

Sponsors and Collaborators

  • Number 2 Children's Hospital, Ho Chi Minh City

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Thuy-Minh-Thu NGUYEN, MD, Number 2 Children's Hospital, Ho Chi Minh City
ClinicalTrials.gov Identifier:
NCT05697887
Other Study ID Numbers:
  • CH2HCM
First Posted:
Jan 26, 2023
Last Update Posted:
Jan 26, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Thuy-Minh-Thu NGUYEN, MD, Number 2 Children's Hospital, Ho Chi Minh City
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2023